Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
Active, not recruiting
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Study for Recalcitrant Age Related Macular Degeneration
Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD
|5||Active, not recruiting||
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
† Study has passed its completion date and status has not been verified in more than two years.